LSO-009 The impact of high-risk antiphospholipid antibodies profile on major organ damage progression in systemic lupus erythematosus: CSTAR multiple prospective cohort study
BackgroundWith the improvement in survival, the prevention of cumulative organ damage has become a major goal in the management of systemic lupus erythematosus (SLE). Patients with autoimmune disease suffered from an increasing risk of cardiovascular disease (23·3 events per 1000 patient-years1). Al...
Saved in:
Published in | Lupus science & medicine Vol. 10; no. Suppl 1; p. A39 |
---|---|
Main Authors | , , , , , |
Format | Journal Article |
Language | English |
Published |
London
BMJ Publishing Group LTD
01.07.2023
BMJ Publishing Group |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Be the first to leave a comment!